Boston — Children who received mRNA COVID-19 vaccines were up to 48% less likely to develop post-COVID conditions (PCCs) if they did contract the disease, a CDC researcher reported… Read More
At the outset, cancer vaccines were plagued with false starts and modest success at best. But they now represent a promising therapeutic strategy in the immunotherapy of solid tumors.
&ldq… Read More
Amidst the ongoing COVID-19 pandemic, concerns have been raised about the safety and composition of certain COVID-19 vaccines. A collaborative study conducted by the University of Guelph, Sy… Read More
BOSTON — Vaccine candidates for chikungunya virus and for the ubiquitous cytomegalovirus performed well in human clinical trials, researchers reported here at the annual IDWeek mee… Read More
Biotech is a hot sector. It’s on the cutting edge of science and technology and that always attracts investor attention. But what is biotech, really, and what are the best biotech stoc… Read More
New research links the rare neurological condition Guillain-Barré syndrome to covid-19. The study tracked millions of people in Israel, finding that those with a recent history of cov… Read More
Presented by 340B Health: Delivered every Tuesday and Friday by 12 p.m., Prescription Pulse examines the latest pharmaceutical news and policy. Oct 17… Read More